Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C20H33NO3.C6H8O7 |
| Molecular Weight | 527.6044 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)CC(O)(CC(O)=O)C(O)=O.CCN(CC)CCOCCOC(=O)C(CC)(CC)C1=CC=CC=C1
InChI
InChIKey=KVKJFNUGVOFNGU-UHFFFAOYSA-N
InChI=1S/C20H33NO3.C6H8O7/c1-5-20(6-2,18-12-10-9-11-13-18)19(22)24-17-16-23-15-14-21(7-3)8-4;7-3(8)1-6(13,5(11)12)2-4(9)10/h9-13H,5-8,14-17H2,1-4H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)
DescriptionSources: http://www.drugbank.ca/drugs/DB04822Curator's Comment: Description was created based on several sources, including http://www.fda.gov.ph/consumers-corner/registered-drugs-2/337707-DR-X1387
Sources: http://www.drugbank.ca/drugs/DB04822
Curator's Comment: Description was created based on several sources, including http://www.fda.gov.ph/consumers-corner/registered-drugs-2/337707-DR-X1387
Oxeladin citrate is a cough suppressant, is a highly potent and effective drug used to treat all types of cough of various etiologies. Withdrawn from the Canadian, US, and UK markets in 1976 due to carcinogenicity. Oxeladine is a component of antitussive drug, Altussan, approved in Philippines.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
52432-72-1
Created by
admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
|
PRIMARY | |||
|
m8299
Created by
admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
|
PRIMARY | Merck Index | ||
|
40384
Created by
admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
|
PRIMARY | |||
|
257-910-8
Created by
admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
|
PRIMARY | |||
|
100000085506
Created by
admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
|
PRIMARY | |||
|
SUB03567MIG
Created by
admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
|
PRIMARY | |||
|
54239
Created by
admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
|
PRIMARY | RxNorm | ||
|
16485-39-5
Created by
admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
|
SUPERSEDED | |||
|
CHEMBL1500276
Created by
admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
|
PRIMARY | |||
|
5AEV5C340C
Created by
admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
|
PRIMARY | |||
|
759231
Created by
admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
|
PRIMARY | |||
|
DTXSID4046608
Created by
admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
|
PRIMARY | |||
|
DBSALT002252
Created by
admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
|
PRIMARY | |||
|
C005461
Created by
admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD
